Form 8-K - Current report:
SEC Accession No. 0001570562-26-000064
Filing Date
2026-05-04
Accepted
2026-05-04 16:05:48
Documents
13
Period of Report
2026-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eols-20260504.htm   iXBRL 8-K 27284
2 EX-99.1 q12026eolsex991.htm EX-99.1 170884
6 EOLS LOGO image.jpg GRAPHIC 10269
  Complete submission text file 0001570562-26-000064.txt   347125

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20260504.xsd EX-101.SCH 1792
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20260504_lab.xml EX-101.LAB 22530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20260504_pre.xml EX-101.PRE 13053
16 EXTRACTED XBRL INSTANCE DOCUMENT eols-20260504_htm.xml XML 2729
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

EIN.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38381 | Film No.: 26937510
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)